Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Incidence of AEs According to Monoclonal Antibody Exposure.
| Monoclonal Antibodies | Combined Therapy |
mAb Therapy |
||
|---|---|---|---|---|
| Exposures | Exposures With ≥1 AE (%) | Exposures | Exposures With ≥1 AE (%) | |
| Ado-trastuzumab emtansine | 17 | 1 (5.8) | — | — |
| Bevacizumab | 188 | 32 (17.0) | 18 | 9 (50.0) |
| Cetuximab | 146 | 20 (13.7) | 4 | 2 (50.0) |
| Ofatumumab | — | — | 3 | 2 (66.7) |
| Panitumumab | 12 | 1 (8.3) | 1 | 1 (100.0) |
| Rituximab | 4 | 0 | 6 | 1 (16.7) |
| Trastuzumab | 107 | 7 (6.5) | 36 | 3 (8.3) |
Abbreviations: AE, adverse event; mAb, monoclonal antibodies.
